Tech Company Financing Transactions
Scilex Pharmaceuticals Funding Round
Scilex Pharmaceuticals, based in San Diego, raised $479.9 thousand from private investors.
Transaction Overview
Company Name
Announced On
5/18/2016
Transaction Type
Venture Equity
Amount
$479,930
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 9 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4955 Directors Pl.
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Not Recorded
Overview
Scilex Pharmaceuticals is a U.S. specialty pharmaceutical company committed to developing and commercia lizing pharmaceutical product s for the treatment of pain . We use our network of global relationships to ac quire high barrier - to - entry, late - stage products where we have proven expertise.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Henry Ji
Chief Medical Officer
Kalpana Patel
Chief Operating Officer
William Pedranti
Vice President
Michael Sweeting
VP - Bus. Development
George Ng
VP - Marketing
Chris Duncan
VP - R & D
Kip Vought
VP - Sales
Matthew Hoenecke
Browse more venture capital transactions:
Prev: 5/18/2016: Virtual Health venture capital transaction
Next: 5/18/2016: Agenovir venture capital transaction
Share this article
About Database of VC Transactions
We do our best to record tech company VC transactions. VC investment data records reported here are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs